Dapiprazole Hydrochloride

CAS 72822-13-0C19H28ClN5MW 361.9

Dapiprazole Hydrochloride (CAS 72822-13-0) — formula C19H28ClN5, molecular weight 361.9.

Product Overview

CAS Number	72822-13-0
Molecular Formula	C19H28ClN5
Molecular Weight	361.9

Technical Profile

What this product is

Dapiprazole Hydrochloride is a chemical compound with CAS registry number 72822-13-0 and molecular formula C19H28ClN5 (molecular weight 361.9).

Identification

CAS number: 72822-13-0

Its molecular formula C19H28ClN5 comprises 19 C, 28 H, 1 Cl, 5 N atoms.

Also known as: Dapiprazole Hydrochloride · 盐酸达哌唑

Frequently Asked Questions

What is the CAS number of Dapiprazole Hydrochloride?

The CAS registry number of Dapiprazole Hydrochloride is 72822-13-0.

What is the molecular formula and molecular weight of Dapiprazole Hydrochloride?

Molecular formula C19H28ClN5, molecular weight 361.9.

What other names is Dapiprazole Hydrochloride known by?

It is also registered under: Dapiprazole Hydrochloride, 盐酸达哌唑.

PubChem Public Data

Independent reference data for Dapiprazole Hydrochloride (CAS 72822-13-0), compiled from public chemistry databases.

Registry identifiers across databases

CAS Registry Number	72822-13-0
PubChem CID	6917787
Molecular formula	C19H28ClN5
IUPAC name	3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;hydrochloride
UNII (FDA)	DS9UJN1I0X

Computed descriptors

Molecular Weight	361.9
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	4
Exact Mass	361.2033236
Monoisotopic Mass	361.2033236
Topological Polar Surface Area	37.2
Heavy Atom Count	25

Documented uses on record

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.

Synonyms and trade names

Dapiprazole hydrochloride; 72822-13-0; Dapiprazole HCl; Rev-Eyes; Dapiprazole monohydrochloride; AF 2139; DTXSID7048669; DS9UJN1I0X; AF-2139; DTXCID4028595; RefChem:57622; 3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-5,6,7,8,-tetrahydro-1,2,4-triazolo(4,3-a)pyridine hydrochloride; Dapiprazole (hydrochloride); DAPIPRAZOLEHYDROCHLORIDE; Glamidolo; 3-(2-(4-(o-tolyl)piperazin-1-yl)ethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine hydrochloride

GHS hazard classification

Reported hazard statements	H315 (100%), H319 (100%)

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

What the public record says

Dapiprazole Hydrochloride · CAS 72822-13-0 · C19H28ClN5. UNII DS9UJN1I0X.

Source: PubChem / Wikidata; the batch COA governs where values differ.